Specialist Claims AI Technology is Beneficial for Detecting Lung Cancer
A leading cancer expert stated on Saturday that technology driven by artificial intelligence (AI) holds considerable promise in assisting doctors with the screening and diagnosis of lung cancer.
TroibNews 
Artificial intelligence (AI) holds substantial promise for aiding doctors in the screening and diagnosis of lung cancer, a prominent cancer expert stated on Saturday.
AI can be effectively utilized in lung cancer screening, which often entails repetitive and labor-intensive procedures. Dr. He Jianxing, director of the National Center for Respiratory Medicine, explained in an interview with CN in Beijing that employing AI to take over these repetitive tasks presents a viable solution.
"As technology develops, we can also implement AI to help evaluate lung function and tumor malignancy levels," he added.
Nevertheless, Dr. He emphasized that AI will not replace doctors at this current time. "It allows doctors to focus on more advanced tasks," he noted. "In the era of big data, doctors are responsible for integrating technologies from different fields, rather than spending excessive time on repetitive tasks."
These comments were made during a meeting commemorating the 40th anniversary of the Cancer Foundation of China, which aims to enhance lung cancer awareness and treatment advancements. November is also recognized as Lung Cancer Awareness Month, an initiative introduced by the Global Lung Cancer Coalition in 2001.
China has witnessed an increasing implementation of AI technologies within the medical sector. In July of this year, researchers from the Air Force Medical University, Tsinghua University, and AI software provider SenseTime released the country's first large pathology model, PathOrchestra, capable of examining over 20 human organs, including the breast, liver, and lungs, as reported by Xinhua.
Lung cancer continues to be the deadliest cancer worldwide. In China alone, around 1.06 million new cases were reported in 2022, according to the National Health Commission. The International Agency for Research on Cancer indicated that nearly 2.5 million individuals were diagnosed with lung cancer globally and more than 1.8 million succumbed to the disease in 2022.
During the meeting, experts also pointed out some concerning trends in China, particularly the increase in lung cancer cases among women.
"In the past, smoking was uncommon among Chinese women. In recent years, however, women have begun to view smoking as a fashion statement," said Dr. Qiao Youlin, a professor at the Chinese Academy of Medical Sciences and Peking Union Medical College’s School of Population Medicine and Public Health.
According to 2020 statistics, while the smoking rate among male residents in China dropped by 14.5 percent over the previous decade, the rate among females rose from 1.5 percent to 3.3 percent, as reported by Life Times.
At the meeting on Saturday, doctors engaged in discussions on a variety of topics, including tobacco control and the importance of early screening for lung cancer.
Established in 1984, the Cancer Foundation of China has made significant strides in patient care programs, international collaborations, cervical cancer initiatives, medication assistance for disadvantaged patients, and educational aid for children of cancer patients, as noted by Dr. Zhi Xiuyi, the foundation’s deputy secretary general, in his remarks to CN.
Lucas Dupont contributed to this report for TROIB News
AI can be effectively utilized in lung cancer screening, which often entails repetitive and labor-intensive procedures. Dr. He Jianxing, director of the National Center for Respiratory Medicine, explained in an interview with CN in Beijing that employing AI to take over these repetitive tasks presents a viable solution.
"As technology develops, we can also implement AI to help evaluate lung function and tumor malignancy levels," he added.
Nevertheless, Dr. He emphasized that AI will not replace doctors at this current time. "It allows doctors to focus on more advanced tasks," he noted. "In the era of big data, doctors are responsible for integrating technologies from different fields, rather than spending excessive time on repetitive tasks."
These comments were made during a meeting commemorating the 40th anniversary of the Cancer Foundation of China, which aims to enhance lung cancer awareness and treatment advancements. November is also recognized as Lung Cancer Awareness Month, an initiative introduced by the Global Lung Cancer Coalition in 2001.
China has witnessed an increasing implementation of AI technologies within the medical sector. In July of this year, researchers from the Air Force Medical University, Tsinghua University, and AI software provider SenseTime released the country's first large pathology model, PathOrchestra, capable of examining over 20 human organs, including the breast, liver, and lungs, as reported by Xinhua.
Lung cancer continues to be the deadliest cancer worldwide. In China alone, around 1.06 million new cases were reported in 2022, according to the National Health Commission. The International Agency for Research on Cancer indicated that nearly 2.5 million individuals were diagnosed with lung cancer globally and more than 1.8 million succumbed to the disease in 2022.
During the meeting, experts also pointed out some concerning trends in China, particularly the increase in lung cancer cases among women.
"In the past, smoking was uncommon among Chinese women. In recent years, however, women have begun to view smoking as a fashion statement," said Dr. Qiao Youlin, a professor at the Chinese Academy of Medical Sciences and Peking Union Medical College’s School of Population Medicine and Public Health.
According to 2020 statistics, while the smoking rate among male residents in China dropped by 14.5 percent over the previous decade, the rate among females rose from 1.5 percent to 3.3 percent, as reported by Life Times.
At the meeting on Saturday, doctors engaged in discussions on a variety of topics, including tobacco control and the importance of early screening for lung cancer.
Established in 1984, the Cancer Foundation of China has made significant strides in patient care programs, international collaborations, cervical cancer initiatives, medication assistance for disadvantaged patients, and educational aid for children of cancer patients, as noted by Dr. Zhi Xiuyi, the foundation’s deputy secretary general, in his remarks to CN.
Lucas Dupont contributed to this report for TROIB News
